In the context of its Private Excellence Initiative Johanna Quandt, Stiftung Charité is announcing three funding programs for international scientists – tailored to your respective career situation.
1. EINSTEIN BIH VISITING FELLOWS
• top-level scientists who remain employed by their home institutions abroad but simultaneously establish a working group in Berlin and are regularly available there
• up to 450,000 euro for three years (can be extended by a further two years) for expense allowances for the Fellow and for personnel and material resources to establish the working group
2. HUMBOLDT RESEARCH FELLOWS AT BIH
• established or younger exceptionally qualified early career scientists from abroad (or already having been in Germany for a maximum of six months) who wish to work on a life science research project in Berlin
• 3,150 euro a month for 6 to 18 months (can be split up) for experienced scientists (four to twelve years after having completed a doctorate) or 2,650 euro a month for 6 to 24 months for postdoctoral researchers (up to four years after having completed a doctorate)
• several additional benefits and integration in the prestigious Humboldt Network
• significantly better prospects for the promotion of positively reviewed applications than with the subject and institution independent Humboldt Research Fellowships
3. BIH SHORT-TERM FELLOWS
• young early career scientists from abroad who conduct a clearly defined research project in the life sciences and wish to lay the foundations for an academic career in Germany
• 2,500 euro a month for up to 12 months plus travelling allowance
• good opportunities for further funding, e.g. via a Humboldt Research Fellowship at BIH (see above)
Plan your research stay now together with an academic host at BIH, Charité – Universitätsmedizin Berlin or Max Delbrück Center for Molecular Medicine.
Applications have to be submitted by you (Humboldt Research Fellowships at the BIH) or your host (Einstein BIH Visiting Fellows und BIH Short-term Fellows) ** by January 15, 2016 at the latest **.